E. Jan Irvine, MD, FRCP(C), MSc
Irvine EJ. Natalizumab increased clinical remission and clinical response in moderate-to-severe Crohn disease. ACP J Club. 2003;139:44. doi: 10.7326/ACPJC-2003-139-2-044
Download citation file:
Published: ACP J Club 2003;139(2):44.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use